详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

VERY LOW-DOSE DECITABINE IS EFFECTIVE IN TREATING INTERMEDIATE OR HIGH RISK MYELODYSPLASTIC SYNDROME

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

机构： [a]Fu-Xing Hospital, Capital Medical College, Beijing , China [b]Xuanwu Hospital, Capital Medical College, Beijing , China [c]Beijing Friendship Hospital, Capital Medical College, Beijing , China [d]The 309th Military Hospital of Chinese People’s Liberation Army, affiliated to Capital Medical College, Beijing , China [e]Beijing Chao-Yang Hospital,Beijing , China [f]First Affiliated Hospital of PLA General Hospital, Beijing , China [g]Beijing Chuiyangliu Hospital, Beijing , China [h]Beijing Tsinghua Changgung Hospital, Beijing , China [i]Beijing Hospital,Beijing , China [j]Beijing Tongren Hospital,Beijing , China [k]Chinese People’s Liberation Army Rocket Army Hospital, Beijing , China [l]PLA Army General Hospital, Beijing , China [m]Beijing Aerospace Center Hospital, Beijing , China [n]Peking Union Medical College Hospital, Beijing , China

出处：

DOI：

ISSN：

关键词： Myelodysplastic syndrome Decitabine Very low dose Efficacy Cost

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2016]版：

大类 | 3 区医学

小类 | 3 区血液学 4 区肿瘤学

最新[2025]版：

大类 | 4 区医学

小类 | 4 区血液学 4 区肿瘤学

JCR分区：

出版当年[2015]版：

Q3 HEMATOLOGY Q3 ONCOLOGY

最新[2024]版：

Q3 HEMATOLOGY Q3 ONCOLOGY

影响因子： 2.2 最新[2024版] 2.3 最新五年平均 2.606 出版当年[2015版] 2.507 出版当年五年平均 2.351 出版前一年[2014版] 2.501 出版后一年[2016版]

第一作者：

第一作者机构： [n]Peking Union Medical College Hospital, Beijing , China

通讯作者：

通讯机构： [n]Peking Union Medical College Hospital, Beijing , China [*1]Department of Hematology Peking Union Medical College Hospital, No. 1 Shuaifuyuan Dongcheng District, Beijing 100730 (China)

推荐引用方式(GB/T 7714)：

APA：

MLA：

VERY LOW-DOSE DECITABINE IS EFFECTIVE IN TREATING INTERMEDIATE OR HIGH RISK MYELODYSPLASTIC SYNDROME

文献详情

相关文献